X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (142) 142
humans (130) 130
double-blind (115) 115
parkinson's disease (101) 101
parkinson disease - drug therapy (84) 84
clinical neurology (83) 83
rasagiline (82) 82
delayed-start trial (79) 79
delayed-start (78) 78
levodopa (61) 61
pharmacology & pharmacy (52) 52
neurosciences (51) 51
animals (43) 43
neuroprotection (43) 43
clinical trials (41) 41
antiparkinson agents - therapeutic use (39) 39
disease progression (39) 39
male (39) 39
motor fluctuations (38) 38
neuroprotective agents - therapeutic use (37) 37
female (35) 35
progression (33) 33
indans - therapeutic use (32) 32
treatment outcome (29) 29
clinical trials as topic (26) 26
middle aged (25) 25
neurology (24) 24
aged (23) 23
selegiline (22) 22
parkinson disease - physiopathology (21) 21
analysis (20) 20
monoamine oxidase inhibitors - therapeutic use (20) 20
drug therapy (19) 19
parkinsons-disease (18) 18
research (18) 18
indans - pharmacology (17) 17
parkinson disease - therapy (17) 17
disease modification (16) 16
double-blind method (16) 16
neuroprotective agents - pharmacology (16) 16
parkinson disease - diagnosis (16) 16
therapy (16) 16
alpha-synuclein (15) 15
alzheimers-disease (15) 15
care and treatment (15) 15
development and progression (15) 15
dopamine (15) 15
indans - adverse effects (15) 15
placebo-controlled trial (15) 15
adult (14) 14
alzheimer's disease (14) 14
monoamine oxidase (14) 14
parkinson disease - complications (14) 14
parkinsons disease (14) 14
time factors (14) 14
disease models, animal (13) 13
dopamine agonists (13) 13
levodopa - therapeutic use (13) 13
monoamine oxidase inhibitors - pharmacology (13) 13
coenzyme q (12) 12
drug therapy, combination (12) 12
health aspects (12) 12
monoamine-oxidase-b (12) 12
quality-of-life (12) 12
research design (12) 12
substantia-nigra (12) 12
treatment (12) 12
antiparkinson agents - adverse effects (11) 11
disease (11) 11
neurodegenerative diseases (11) 11
nonmotor symptoms (11) 11
quality of life (11) 11
randomized controlled-trial (11) 11
rating-scale (11) 11
severity of illness index (11) 11
antiparkinson agents - pharmacology (10) 10
cognition (10) 10
delayed start design (10) 10
efficacy (10) 10
follow-up studies (10) 10
indans - administration & dosage (10) 10
monoamine oxidase inhibitors - adverse effects (10) 10
oxidative stress (10) 10
pramipexole (10) 10
psychiatry (10) 10
studies (10) 10
usage (10) 10
antiparkinson agents - administration & dosage (9) 9
diagnosis (9) 9
disability (9) 9
dopa (9) 9
early parkinson-disease (9) 9
l-dopa (9) 9
medical research (9) 9
parkinson disease - metabolism (9) 9
parkinson disease - pathology (9) 9
statistics & probability (9) 9
trial (9) 9
abridged index medicus (8) 8
adagio (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2014, Volume 20, Issue 6, pp. 640 - 643
Abstract Background The ADAGIO study included a large cohort of patients with early PD (baseline total-UPDRS = 20) who were initially randomized to rasagiline... 
Neurology | Monotherapy | Rasagiline | Parkinson's disease | DELAYED-START TRIAL | DOUBLE-BLIND | THERAPIES | CLINICAL NEUROLOGY | Neuroprotective Agents - therapeutic use | Double-Blind Method | Humans | Motor Activity - drug effects | Female | Male | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Indans - therapeutic use | Cohort Studies | Analysis | Index Medicus
Journal Article
Journal Article
Nature Reviews Neurology, ISSN 1759-4758, 03/2010, Volume 6, Issue 3, pp. 126 - 128
the results of the ADAGIO trial, combined with those of the TEMPO trial and a large body of additional clinical and preclinical data, indicate that the... 
CLINICAL NEUROLOGY | DELAYED-START | Neuroprotective Agents - therapeutic use | Time Factors | Humans | Clinical Trials as Topic | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Indans - therapeutic use | Disease Progression | Drug Delivery Systems
Journal Article
Reproductive Biology and Endocrinology, ISSN 1477-7827, 12/2018, Volume 16, Issue 1, pp. 1 - 7
Background Recently, a novel approach with delaying the start of controlled ovarian stimulation along with gonadotropin-releasing hormone (GnRH) antagonist... 
In vitro fertilization | Follicle-stimulating hormone | Statistical analysis | Fertilization | Sperm | Clinical trials | Pituitary (anterior) | Gonadotropins | Follicles | Embryos | Patients | Oocytes | Pregnancy | Infertility | Gonadotropin-releasing hormone | Conventional protocol | Bologna criteria | Poor responders | GnRH antagonist | Delayed start protocol
Journal Article
Statistics in Biopharmaceutical Research, ISSN 1946-6315, 10/2017, Volume 9, Issue 4, pp. 390 - 398
In this article, we propose a novel slope analysis which we call the divergence effect analysis. The slope analysis has been used in disease-modifying... 
Disease-modifying treatment | Divergence effect | Slope analysis | Delayed-start trial | ALZHEIMER-DISEASE | DESIGN | DELAYED-START | MATHEMATICAL & COMPUTATIONAL BIOLOGY | STATISTICS & PROBABILITY | PARKINSONS-DISEASE
Journal Article
Journal Article
Reproductive Sciences, ISSN 1933-7191, 12/2015, Volume 22, Issue 12, pp. 1627 - 1631
Journal Article